4 terminated, 3 completed. 7 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Terminated 4, Completed 3 |
Follow Exubera: new trials by email Literature Review of Exubera trials Research Report on Exubera
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety And Efficacy Of Exubera Compared With Subcutaneous Human Insulin Therapy In Children And Adolescents Inhaled insulin (Exubera), Subcutaneous Insulin (subject's prescribed) - Diabetes Mellitus, Type 1 | Phase 3 | Terminated | Pfizer | 2 | 2007-10-01 | 2018-10-01 |
| Long-Term Safety Study Of Inhaled Insulin (CP-464,005, Inhaler) In Japanese Patients With Type1 or Type2 Diabetes CP-464,005 - Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1 | Phase 3 | Terminated | Pfizer | 24 | 2007-08-01 | 2009-10-15 |
| Exubera vs Lispro in a Lantus-based Regimen for Improved Glycemic Control in Type 2 Diabetes Insulin Lispro, Exubera - Diabetes Mellitus | Phase 3 | Completed | Pfizer | 191 | 2006-06-01 | 2010-03-16 |
| A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes Mellitus Inhaled Insulin (Exubera), Standard of Care - Diabetes Mellitus Type 2 | Phase 3 | Terminated | Pfizer | 354 | 2006-03-06 | 2019-04-02 |
| US Inhaled Insulin Dose Titration Study Exubera (inhaled insulin), 8-point glucose diary (to assess pre- and post prandial glucoses), Meal Tolerance Test - Diabetes Mellitus, Type 2 | Phase 3 | Completed | Pfizer | 120 | 2005-11-01 | 2008-02-08 |
| Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 2 Diabetes Inhaled Insulin, Subcutaneous insulin - Diabetes Mellitus | Phase 3 | Terminated | Pfizer | 635 | 2002-06-01 | 2010-02-18 |
| Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 2 Diabetes Inhaled human insulin (EXUBERA™) - Diabetes Mellitus, Type 2 | Phase 3 | Completed | Pfizer | 300 | 1999-09-01 | 2007-02-13 |
Diabetes Mellitus, Type 2 (4) · Diabetes Mellitus (3) · Diabetes Mellitus, Type 1 (2) · Insulin Resistance (1)
Pfizer (7)
United States (5) · Canada (3) · Puerto Rico (2) · Brazil (1) · France (1) · Greece (1) · Japan (1) · Portugal (1) · Spain (1) · Sweden (1) · Turkey (Türkiye) (1)
2005 (1)